Seres Therapeutics (MCRB) Earnings Dates, Call Summary & Reports

The P/E ratio of {name} is N/A.

0 Followers

Earnings Data

Report Date

Nov 11, 2026

Before Open (Confirmed)

Period Ending

2026 (Q3)

Consensus EPS Forecast

-0.81

Last Year’s EPS

0.76

Same Quarter Last Year

Moderate Buy

Based on 2 Analysts Ratings

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CH:MCRB Upcoming Earnings

Seres Therapeutics's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 11, 2026	2026 (Q3)	-0.81 / -	0.761	―	―	―
Aug 05, 2026	2026 (Q2)	-1.77 / 0.38	-1.839	120.70% (+2.22)	―	―
May 05, 2026	2026 (Q1)	-1.52 / -1.68	3.037	-155.47% (-4.72)	―	―
Mar 12, 2026	2025 (Q4)	-1.71 / -1.44	-1.458	1.11% (+0.02)	―	―
Nov 05, 2025	2025 (Q3)	0.37 / 0.76	9.395	-91.90% (-8.63)	―
Aug 06, 2025	2025 (Q2)	-2.02 / -1.84	-3.564	48.41% (+1.73)	―
May 07, 2025	2025 (Q1)	0.08 / 3.04	-4.374	169.44% (+7.41)	―
Mar 13, 2025	2024 (Q4)	-3.18 / -1.46	-5.022	70.97% (+3.56)	―
Nov 13, 2024	2024 (Q3)	-1.26 / 9.40	-5.993	256.76% (+15.39)	―
Aug 13, 2024	2024 (Q2)	-4.44 / -3.56	5.831	-161.11% (-9.40)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

When does Seres Therapeutics (CH:MCRB) report earnings?

Seres Therapeutics (CH:MCRB) is schdueled to report earning on Nov 11, 2026, Before Open (Confirmed).

What is Seres Therapeutics (CH:MCRB) earnings time?

Seres Therapeutics (CH:MCRB) earnings time is at Nov 11, 2026, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is the P/E ratio of Seres Therapeutics stock?

The P/E ratio of Seres Therapeutics is N/A.

What is CH:MCRB EPS forecast?

CH:MCRB EPS forecast for the fiscal quarter 2026 (Q3) is -0.81.